Best's Review Leaders Issue Ranks Top Global Brokers and More

Best’s Review (July issue) ranked the Top 20 Global Insurance Brokers by 2025 total revenue and included rankings across US P/C writers, US life/health insurers, and Canada public insurers. The article also highlighted New York Life’s AI integration plans, aimed at reimagining end-to-end processes rather than incremental productivity gains. Overall, this is primarily informational with limited immediate market-moving impact.

Analysis

The real signal here is not the ranking itself; it is that insurance is a scale business where data density and workflow ownership increasingly matter more than raw distribution headcount. That favors the top broker platforms and the largest carriers, because they can amortize AI, compliance, and cyber spend across a much larger premium base while smaller competitors face a higher fixed-cost burden. Over time, that should widen the gap in operating leverage and client retention for names like MMC, AON, and WTW versus regional brokers and fragmented administrators.

For life insurers, AI is most likely a margin story, not a revenue story. The first measurable benefit should show up in service costs, underwriting turnaround, and persistency, but only if management actually re-engineers policy administration rather than adding a chatbot layer on top of legacy systems. The 1-3 month catalyst is commentary on expense ratios and workflow automation; the 6-18 month catalyst is whether these savings flow into reported operating income rather than being absorbed by higher tech and governance spend.

Contrarian view: the market may be overrating near-term AI monetization in regulated financials. Insurance data is messy, model approval is slow, and implementation risk is high, so a lot of the value may accrue to vendors and consultants before it reaches equity holders. That argues for patience: the best trades are likely relative-value expressions on proven scale franchises, not outright longs on generic AI enthusiasm.

Key Decisions for Investors

• No high-conviction trade in BSAA on this item alone; treat as a watchpoint until next earnings cycle shows actual expense-ratio or operating-margin improvement.
• If seeking exposure, prefer a 3-6 month relative long in scaled brokers (MMC/AON/WTW basket) versus smaller regional brokers or fragmented service providers; thesis is wider operating leverage and better AI absorption.
• Avoid chasing pure-play AI suppliers on this headline; the incremental spend is more likely to be internalized by insurers and diluted across vendors than to create immediate earnings upside for software names.
• Set an alert for the next two quarterly reports from large life insurers and brokers: thesis is falsified if SG&A stays flat-to-up while management continues to flag elevated tech/governance costs with no operating leverage.
• Use pullbacks in the insurance ETF complex (KIE/IAK) only if commentary confirms admin-cost takeout; otherwise stay neutral and wait for proof rather than paying for the narrative.